Education
About Us
Working with TipRanks
Follow Us
Janux Therapeutics Inc (JANX)
NASDAQ:JANX
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 10.00M | $ 10.59M | $ 8.08M | $ 8.61M | $ 3.64M |
| Gross Profit | $ 7.97M | $ 8.53M | $ 6.13M | $ 7.77M | $ 3.64M |
| Operating Income | $ -157.67M | $ -98.85M | $ -72.98M | $ -67.09M | $ -32.93M |
| EBITDA | $ -113.63M | $ -96.79M | $ -71.02M | $ -66.25M | $ -32.82M |
| Net Income | $ -157.67M | $ -68.99M | $ -58.29M | $ -63.06M | $ -32.67M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 966.57M | $ 1.03B | $ 344.03M | $ 327.02M | $ 374.96M |
| Total Assets | $ 1.00B | $ 1.06B | $ 380.41M | $ 364.01M | $ 379.82M |
| Total Debt | $ 22.14M | $ 23.02M | $ 24.54M | $ 25.30M | $ 194.00K |
| Net Debt | $ -30.20M | $ -407.58M | $ 5.34M | $ -26.12M | $ -35.39M |
| Total Liabilities | $ 44.74M | $ 38.73M | $ 36.06M | $ 43.27M | $ 13.50M |
| Stockholders' Equity | $ 956.82M | $ 1.02B | $ 344.35M | $ 320.74M | $ 366.33M |
| Cash Flow | |||||
| Free Cash Flow | $ -83.28M | $ -44.17M | $ -52.42M | $ -49.37M | $ -18.46M |
| Operating Cash Flow | $ -82.23M | $ -43.81M | $ -50.58M | $ -42.92M | $ -16.98M |
| Investing Cash Flow | $ -300.98M | $ -258.02M | $ -41.19M | $ 58.27M | $ -340.96M |
| Financing Cash Flow | $ 4.95M | $ 713.24M | $ 59.55M | $ 500.00K | $ 386.52M |